The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetic Retinopathy (DR) Analysis Software Market Research Report 2024
Synopsis
The software is artificial intelligence-based, composed of automated DR screening and mobile or hardware components. The goal is to bring long term and cheap diabetic retinopathy screening to diabetic patients through ML or mobile phones. The core technique for the analysis is deep learning module, and with the web interfaces, both doctors and patients could visually understand the results.
The global Diabetic Retinopathy (DR) Analysis Software market was valued at US$ 1207 million in 2023 and is anticipated to reach US$ 2045.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Analysis Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Analysis Software.
Report Scope
The Diabetic Retinopathy (DR) Analysis Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Retinopathy (DR) Analysis Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Retinopathy (DR) Analysis Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Evolucare
IDx Technologies Inc.
Yingtong
Vistel
MONA
Eyenuk
Google Health
Optos
Zeiss
Heidelberg Engineering
Topcon Medical Systems
RetinAI
Remidio Innovative Solutions
Segment by Type
AI Screening System
AI Analysis (Disease Assessment)
Segment by Application
Clinical Diagnoses
Personal Triage
Investigational Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Analysis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The software is artificial intelligence-based, composed of automated DR screening and mobile or hardware components. The goal is to bring long term and cheap diabetic retinopathy screening to diabetic patients through ML or mobile phones. The core technique for the analysis is deep learning module, and with the web interfaces, both doctors and patients could visually understand the results.
The global Diabetic Retinopathy (DR) Analysis Software market was valued at US$ 1207 million in 2023 and is anticipated to reach US$ 2045.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Analysis Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Analysis Software.
Report Scope
The Diabetic Retinopathy (DR) Analysis Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Retinopathy (DR) Analysis Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Retinopathy (DR) Analysis Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Evolucare
IDx Technologies Inc.
Yingtong
Vistel
MONA
Eyenuk
Google Health
Optos
Zeiss
Heidelberg Engineering
Topcon Medical Systems
RetinAI
Remidio Innovative Solutions
Segment by Type
AI Screening System
AI Analysis (Disease Assessment)
Segment by Application
Clinical Diagnoses
Personal Triage
Investigational Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Analysis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 AI Screening System
1.2.3 AI Analysis (Disease Assessment)
1.3 Market by Application
1.3.1 Global Diabetic Retinopathy (DR) Analysis Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnoses
1.3.3 Personal Triage
1.3.4 Investigational Use
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Perspective (2019-2030)
2.2 Diabetic Retinopathy (DR) Analysis Software Growth Trends by Region
2.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Region (2019-2024)
2.2.3 Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2025-2030)
2.3 Diabetic Retinopathy (DR) Analysis Software Market Dynamics
2.3.1 Diabetic Retinopathy (DR) Analysis Software Industry Trends
2.3.2 Diabetic Retinopathy (DR) Analysis Software Market Drivers
2.3.3 Diabetic Retinopathy (DR) Analysis Software Market Challenges
2.3.4 Diabetic Retinopathy (DR) Analysis Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue
3.1.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue (2019-2024)
3.1.2 Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Retinopathy (DR) Analysis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetic Retinopathy (DR) Analysis Software Revenue
3.4 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio
3.4.1 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy (DR) Analysis Software Revenue in 2023
3.5 Diabetic Retinopathy (DR) Analysis Software Key Players Head office and Area Served
3.6 Key Players Diabetic Retinopathy (DR) Analysis Software Product Solution and Service
3.7 Date of Enter into Diabetic Retinopathy (DR) Analysis Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Type
4.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Type (2019-2024)
4.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2025-2030)
5 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Application
5.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Application (2019-2024)
5.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)
6.2 North America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)
6.4 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)
7.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)
7.4 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)
8.2 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)
9.2 Latin America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)
9.4 Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)
10.2 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Evolucare
11.1.1 Evolucare Company Detail
11.1.2 Evolucare Business Overview
11.1.3 Evolucare Diabetic Retinopathy (DR) Analysis Software Introduction
11.1.4 Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.1.5 Evolucare Recent Development
11.2 IDx Technologies Inc.
11.2.1 IDx Technologies Inc. Company Detail
11.2.2 IDx Technologies Inc. Business Overview
11.2.3 IDx Technologies Inc. Diabetic Retinopathy (DR) Analysis Software Introduction
11.2.4 IDx Technologies Inc. Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.2.5 IDx Technologies Inc. Recent Development
11.3 Yingtong
11.3.1 Yingtong Company Detail
11.3.2 Yingtong Business Overview
11.3.3 Yingtong Diabetic Retinopathy (DR) Analysis Software Introduction
11.3.4 Yingtong Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.3.5 Yingtong Recent Development
11.4 Vistel
11.4.1 Vistel Company Detail
11.4.2 Vistel Business Overview
11.4.3 Vistel Diabetic Retinopathy (DR) Analysis Software Introduction
11.4.4 Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.4.5 Vistel Recent Development
11.5 MONA
11.5.1 MONA Company Detail
11.5.2 MONA Business Overview
11.5.3 MONA Diabetic Retinopathy (DR) Analysis Software Introduction
11.5.4 MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.5.5 MONA Recent Development
11.6 Eyenuk
11.6.1 Eyenuk Company Detail
11.6.2 Eyenuk Business Overview
11.6.3 Eyenuk Diabetic Retinopathy (DR) Analysis Software Introduction
11.6.4 Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.6.5 Eyenuk Recent Development
11.7 Google Health
11.7.1 Google Health Company Detail
11.7.2 Google Health Business Overview
11.7.3 Google Health Diabetic Retinopathy (DR) Analysis Software Introduction
11.7.4 Google Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.7.5 Google Health Recent Development
11.8 Optos
11.8.1 Optos Company Detail
11.8.2 Optos Business Overview
11.8.3 Optos Diabetic Retinopathy (DR) Analysis Software Introduction
11.8.4 Optos Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.8.5 Optos Recent Development
11.9 Zeiss
11.9.1 Zeiss Company Detail
11.9.2 Zeiss Business Overview
11.9.3 Zeiss Diabetic Retinopathy (DR) Analysis Software Introduction
11.9.4 Zeiss Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.9.5 Zeiss Recent Development
11.10 Heidelberg Engineering
11.10.1 Heidelberg Engineering Company Detail
11.10.2 Heidelberg Engineering Business Overview
11.10.3 Heidelberg Engineering Diabetic Retinopathy (DR) Analysis Software Introduction
11.10.4 Heidelberg Engineering Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.10.5 Heidelberg Engineering Recent Development
11.11 Topcon Medical Systems
11.11.1 Topcon Medical Systems Company Detail
11.11.2 Topcon Medical Systems Business Overview
11.11.3 Topcon Medical Systems Diabetic Retinopathy (DR) Analysis Software Introduction
11.11.4 Topcon Medical Systems Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.11.5 Topcon Medical Systems Recent Development
11.12 RetinAI
11.12.1 RetinAI Company Detail
11.12.2 RetinAI Business Overview
11.12.3 RetinAI Diabetic Retinopathy (DR) Analysis Software Introduction
11.12.4 RetinAI Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.12.5 RetinAI Recent Development
11.13 Remidio Innovative Solutions
11.13.1 Remidio Innovative Solutions Company Detail
11.13.2 Remidio Innovative Solutions Business Overview
11.13.3 Remidio Innovative Solutions Diabetic Retinopathy (DR) Analysis Software Introduction
11.13.4 Remidio Innovative Solutions Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
11.13.5 Remidio Innovative Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of AI Screening System
Table 3. Key Players of AI Analysis (Disease Assessment)
Table 4. Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2019-2024)
Table 8. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2025-2030)
Table 10. Diabetic Retinopathy (DR) Analysis Software Market Trends
Table 11. Diabetic Retinopathy (DR) Analysis Software Market Drivers
Table 12. Diabetic Retinopathy (DR) Analysis Software Market Challenges
Table 13. Diabetic Retinopathy (DR) Analysis Software Market Restraints
Table 14. Global Diabetic Retinopathy (DR) Analysis Software Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Players (2019-2024)
Table 16. Global Top Diabetic Retinopathy (DR) Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Analysis Software as of 2023)
Table 17. Ranking of Global Top Diabetic Retinopathy (DR) Analysis Software Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Diabetic Retinopathy (DR) Analysis Software Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetic Retinopathy (DR) Analysis Software Product Solution and Service
Table 21. Date of Enter into Diabetic Retinopathy (DR) Analysis Software Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Type (2019-2024)
Table 25. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Type (2025-2030)
Table 27. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Application (2019-2024)
Table 29. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Application (2025-2030)
Table 31. North America Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)
Table 46. Evolucare Company Detail
Table 47. Evolucare Business Overview
Table 48. Evolucare Diabetic Retinopathy (DR) Analysis Software Product
Table 49. Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 50. Evolucare Recent Development
Table 51. IDx Technologies Inc. Company Detail
Table 52. IDx Technologies Inc. Business Overview
Table 53. IDx Technologies Inc. Diabetic Retinopathy (DR) Analysis Software Product
Table 54. IDx Technologies Inc. Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 55. IDx Technologies Inc. Recent Development
Table 56. Yingtong Company Detail
Table 57. Yingtong Business Overview
Table 58. Yingtong Diabetic Retinopathy (DR) Analysis Software Product
Table 59. Yingtong Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 60. Yingtong Recent Development
Table 61. Vistel Company Detail
Table 62. Vistel Business Overview
Table 63. Vistel Diabetic Retinopathy (DR) Analysis Software Product
Table 64. Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 65. Vistel Recent Development
Table 66. MONA Company Detail
Table 67. MONA Business Overview
Table 68. MONA Diabetic Retinopathy (DR) Analysis Software Product
Table 69. MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 70. MONA Recent Development
Table 71. Eyenuk Company Detail
Table 72. Eyenuk Business Overview
Table 73. Eyenuk Diabetic Retinopathy (DR) Analysis Software Product
Table 74. Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 75. Eyenuk Recent Development
Table 76. Google Health Company Detail
Table 77. Google Health Business Overview
Table 78. Google Health Diabetic Retinopathy (DR) Analysis Software Product
Table 79. Google Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 80. Google Health Recent Development
Table 81. Optos Company Detail
Table 82. Optos Business Overview
Table 83. Optos Diabetic Retinopathy (DR) Analysis Software Product
Table 84. Optos Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 85. Optos Recent Development
Table 86. Zeiss Company Detail
Table 87. Zeiss Business Overview
Table 88. Zeiss Diabetic Retinopathy (DR) Analysis Software Product
Table 89. Zeiss Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 90. Zeiss Recent Development
Table 91. Heidelberg Engineering Company Detail
Table 92. Heidelberg Engineering Business Overview
Table 93. Heidelberg Engineering Diabetic Retinopathy (DR) Analysis Software Product
Table 94. Heidelberg Engineering Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 95. Heidelberg Engineering Recent Development
Table 96. Topcon Medical Systems Company Detail
Table 97. Topcon Medical Systems Business Overview
Table 98. Topcon Medical Systems Diabetic Retinopathy (DR) Analysis Software Product
Table 99. Topcon Medical Systems Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 100. Topcon Medical Systems Recent Development
Table 101. RetinAI Company Detail
Table 102. RetinAI Business Overview
Table 103. RetinAI Diabetic Retinopathy (DR) Analysis Software Product
Table 104. RetinAI Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 105. RetinAI Recent Development
Table 106. Remidio Innovative Solutions Company Detail
Table 107. Remidio Innovative Solutions Business Overview
Table 108. Remidio Innovative Solutions Diabetic Retinopathy (DR) Analysis Software Product
Table 109. Remidio Innovative Solutions Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)
Table 110. Remidio Innovative Solutions Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Retinopathy (DR) Analysis Software Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Type: 2023 VS 2030
Figure 3. AI Screening System Features
Figure 4. AI Analysis (Disease Assessment) Features
Figure 5. Global Diabetic Retinopathy (DR) Analysis Software Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Application: 2023 VS 2030
Figure 7. Clinical Diagnoses Case Studies
Figure 8. Personal Triage Case Studies
Figure 9. Investigational Use Case Studies
Figure 10. Diabetic Retinopathy (DR) Analysis Software Report Years Considered
Figure 11. Global Diabetic Retinopathy (DR) Analysis Software Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Diabetic Retinopathy (DR) Analysis Software Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region: 2023 VS 2030
Figure 14. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Players in 2023
Figure 15. Global Top Diabetic Retinopathy (DR) Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Analysis Software as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy (DR) Analysis Software Revenue in 2023
Figure 17. North America Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)
Figure 19. United States Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)
Figure 23. Germany Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2019-2030)
Figure 31. China Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)
Figure 39. Mexico Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)
Figure 43. Turkey Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Evolucare Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 46. IDx Technologies Inc. Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 47. Yingtong Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 48. Vistel Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 49. MONA Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 50. Eyenuk Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 51. Google Health Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 52. Optos Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 53. Zeiss Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 54. Heidelberg Engineering Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 55. Topcon Medical Systems Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 56. RetinAI Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 57. Remidio Innovative Solutions Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
